Skip to main content

Figure 9.

Figure 9

Presumed molecular pathways of development of papillary and nodular carcinoma. (Modified from Wu.( 38 )) CIS, carcinoma in situ; FGFR3, fibroblast growth factor receptor 3; MMPS, matrix metal proteinases; RB, retinoblastoma gene; VEGF, vascular endothelial growth factor.